About

About
The DS management team has both a strong background in developing drugs for the market and experience in building life science companies.

Pipeline

Pipeline
DS Biopharma have two novel assets in various stages of clinical and pre-clinical development and intend to add more bioactive lipids to the current portfolio in the coming years.

Investors

Investors
To date, DS Biopharma have been funded privately.

Latest News

May 8, 2017

DS Biopharma appoints Professor Brendan Buckley as Non-Executive Director

Dublin, Ireland, May 8th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced the appointment of Professor Brendan Buckley as a non-executive director […]
April 13, 2017

DS Biopharma receives a patent allowance for Oral DS107 in the US

Dublin, Ireland, April 13th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced receipt of allowance for a patent application in the United […]

Join our mailing list

Connect with us